# Biological Surgical Options in Young Patients for the Treatment of Severe Aortic Stenosis: Is the Jury Still Out? A Review

## TL;DR

This paper reviews surgical options for young patients with severe aortic stenosis, focusing on bioprosthetic valves, mechanical valves, and the Ross procedure.

## Contribution

The paper provides updated insights into the evolving surgical choices for younger patients with aortic stenosis.

## Key findings

- Bioprosthetic valves are increasingly used in younger patients due to improved durability.
- The Ross procedure is gaining attention but requires specialized centers.
- Anticoagulation therapy remains a challenge for mechanical valves in young patients.

## Abstract

Aortic interventions remain the most effective treatment for severe aortic
stenosis. In the recent years, advances in bioprosthetics and newer data have
reduced the cut-off age for the use of bioprosthetic valves in younger patients,
but the debate on whether to favor mechanical valves in younger patients remains
a constant, especially with the undesired effects and considerations of
anticoagulation therapy with vitamin K antagonists in this age group. Other
options like the Ross procedure are gaining traction, despite still being
undervalued and necessitating expertise centers. Hemodynamic considerations and
durability of these options are important to consider, especially in this age
group. Regardless of the choice of the prosthesis, patient informed consent is
paramount since the decision affects the lifetime management of their initial
condition, and expectations given must remain realistic.